Ocular graft-versus-host disease (GVHD) can cause tear loss, dry eyes, irritation, pain and vision problems and can impact quality of life after transplant. This presentation will discuss symptoms of ocular GVHD and effective treatments.

The eyes are one of the most common sites for graft-versus-host-disease following stem cell transplantation. This presentation describes the most typical forms of ocular GVHD and the wide array of remedies to effectively treat symptoms of this problem. (Note: In this presentation, when the speaker uses the term bone marrow transplants, it includes stem cell and cord blood transplants as well.)

Key Points: (02:43) Dry eyes from GVHD is more severe than common dry eyes and can lead to corneal abrasions . (03:37) Blood vessels can grow into the cornea, cause

Graft-versus-host (GVHD) disease often affects the eyes. Early detection is essential for effective treatment.

Chronic ocular graft-versus-host disease (GVHD) affects more than 50% of patients who have chronic GVHD. A variety of therapies are available and should be approached in a step-ladder manner.

Eyes can be damaged by graft-versus-host disease (GVHD). Treatment options depend on symptoms, but most long-term effects are preventable.

Chronic ocular graft-versus-host disease (GVHD) affects more than 50% of patients who have chronic GVHD. A variety of therapies are available and should be approached in a step-ladder manner.

Chronic graft-versus-host disease (GVHD) often affects the eyes, making it difficult to perform normal, daily functions. It can be the only sign of chronic GVHD, or a signal that chronic GVHD is developing elsewhere in the body, as well.